Molecular Endotypes of Chronic Idiopathic Urticaria
NCT04774315
·
clinicaltrials.gov ↗
PHASE4
Phase
ACTIVE_NOT_RECRUITING
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Chronic Urticaria, Idiopathic
Interventions
DRUG:
Omalizumab
Sponsor
University of Colorado, Denver